Bos, V., F. Crouwel, P. Waaijenberg, G. Bouma, M. Duijvestein, H. Buiter, H. Brand, H. Hamer, and N. de Boer. “Salivary Calprotectin Is Not a Useful Biomarker to Monitor Disease Activity in Patients With Inflammatory Bowel Disease”. Journal of Gastrointestinal and Liver Diseases, Vol. 31, no. 3, Sept. 2022, pp. 283-9, doi:10.15403/jgld-4215.